Clinical Trial Update: Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan. [Phase 2]

View source ↗

Summary

Phase II trial evaluating preoperative Cisplatin-Irinotecan with subsequent radiation and concurrent Cisplatin/Irinotecan for esophageal cancer; the study is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Esophageal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-01-25